ACSL4 and adrenoleukodystrophy: Although no link between ALD pathophysiology and ferroptosis or ACSL4 has been established to‐date, we speculate that inhibition of ACSL4 might also contribute to long‐term beneficial effects of PXL065 (or pioglitazone) to attenuate neuroinflammation or neuronal cell loss in the context of ALD.